Publication:
Highlights of the 2019 Japanese Society of Hypertension Guidelines and perspectives on the management of Asian hypertensive patients

Issued Date

2020-03-01

Resource Type

Review

ISSN

17517176
15246175

DOI

10.1111/jch.13763

Other identifier(s)

2-s2.0-85077889100

Rights

Mahidol University

Rights Holder(s)

SCOPUS

Bibliographic Citation

Journal of Clinical Hypertension. Vol.22, No.3 (2020), 369-377

Suggested Citation

Satoshi Hoshide, Kazuomi Kario, Naoko Tomitani, Tomoyuki Kabutoya, Yook Chin Chia, Sungha Park, Jinho Shin, Yuda Turana, Jam Chin Tay, Peera Buranakitjaroen, Chen Huan Chen, Jennifer Nailes, Huynh Van Minh, Saulat Siddique, Jorge Sison, Arieska Ann Soenarta, Guru Prasad Sogunuru, Apichard Sukonthasarn, Boon Wee Teo, Narsingh Verma, Yuqing Zhang, Tzung Dau Wang, Ji Guang Wang Highlights of the 2019 Japanese Society of Hypertension Guidelines and perspectives on the management of Asian hypertensive patients. Journal of Clinical Hypertension. Vol.22, No.3 (2020), 369-377. doi:10.1111/jch.13763 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/54627

Research Projects

Organizational Units

Authors

Journal Issue

Thesis

Title

Highlights of the 2019 Japanese Society of Hypertension Guidelines and perspectives on the management of Asian hypertensive patients

Author(s)

Satoshi Hoshide
 Kazuomi Kario
 Naoko Tomitani
 Tomoyuki Kabutoya
 Yook Chin Chia
 Sungha Park
 Jinho Shin
 Yuda Turana
 Jam Chin Tay
 Peera Buranakitjaroen
 Chen Huan Chen
 Jennifer Nailes
 Huynh Van Minh
 Saulat Siddique
 Jorge Sison
 Arieska Ann Soenarta
 Guru Prasad Sogunuru
 Apichard Sukonthasarn
 Boon Wee Teo
 Narsingh Verma
 Yuqing Zhang
 Tzung Dau Wang
 Ji Guang Wang

Other Contributor(s)

University Medicine and Pharmacy, Hue University
 De La Salle Health Sciences Institute
 Sunway University
 Hanyang University Medical Center
 Jichi Medical University
 Yonsei University Health System
 Shanghai Jiao Tong University School of Medicine
 Madras Institute of Orthopaedics and Traumatology Hospitals
 National Taiwan University Hospital
 Kathmandu University
 University of the East Ramon Magsaysay Memorial Medical Center
 Fatima Memorial Hospital
 National Yang-Ming University Taiwan
 Universitas Katolik Indonesia Atma Jaya
 Universitas Indonesia
 University of Malaya
 Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
 Yong Loo Lin School of Medicine
 King George's Medical University
 Faculty of Medicine, Siriraj Hospital, Mahidol University
 Tan Tock Seng Hospital
 Bangkok Hospital Chiang Mai

Abstract

© 2019 Wiley Periodicals, Inc. Unlike other international guidelines but in accord with the earlier Japanese Society of Hypertension (JSH) guidelines, the 2019 JSH guidelines (“JSH 2019”) continue to emphasize the importance of out-of-office blood pressure (BP) measurements obtained with a home BP device. Another unique characteristic of JSH 2019 is that it sets clinical questions about the management of hypertension that are based on systematic reviews of updated evidence. JSH 2019 states that individuals with office BP < 140/90 mm Hg do not have normal BP. The final decisions regarding the diagnosis and treatment of hypertension should be performed based on out-of-office BP values together with office BP measurements. For hypertensive adults with comorbidities, the office BP goal is usually <130/80 mm Hg and the home BP goal is <125/75 mm Hg. Recommendations of JSH 2019 would be valuable for not only Japanese hypertensive patients but also Asian hypertensive patients, who share the same features including higher incidence of stroke compared with that of myocardial infarction and a steeper blood pressure-vascular event relationship.

Keyword(s)

Medicine

Availability

URI

https://repository.li.mahidol.ac.th/handle/20.500.14594/54627

Collections

Scopus 2020